The Eurozone economy grew 0.3% in Q4 2025, matching the previous quarter's pace and easing earlier recession fears. However, analysts warn that the euro's sharp 14.4% gain against the dollar over the past year threatens to undermine the competitiveness of European exports.
New Oriental Education & Technology Group (NYSE: EDU) sees its stock momentum bolstered by substantial institutional ownership, which now stands near 49%. Last week's $482 million market cap gain adds to a 22% annual return, highlighting investor faith in the Chinese education giant's post-regulatory overhaul trajectory.
TAIPEI, Jan 30 (Reuters) - Taiwan completed the maiden underwater sea trial for its first domestically developed submarine on Thursday, a big milestone in a project aimed at strengthening deterrence
Pakistani security forces conducted targeted military operations in the restive southwestern Balochistan province, resulting in the deaths of 41 militants. The raids signal an escalation in ongoing efforts to curb insurgent activities in the region.
Deutsche Bank and its asset manager DWS are in preliminary talks to acquire a significant minority stake in Fosun-owned Frankfurter Leben, signaling a strategic reversal a decade after exiting the sector.
Taiwan's economy surged 8.6% in 2025, its fastest growth since 2010, driven by a global AI boom and a landmark trade agreement with the United States. While analysts project a moderation in 2026, the island's pivotal role in the tech supply chain has delivered record profits for its leading firms.
In a late-night social media post, former President Donald Trump threatened to impose a 50% tariff on all Canadian aircraft sold in the U.S. and decertify new planes, citing Canada's alleged refusal to certify Gulfstream jets. The move, targeting Bombardier, risks disrupting U.S. regional aviation and corporate travel.
The Central American nation makes its second major gold purchase in months, fortifying reserves as it balances pioneering Bitcoin bets with traditional safe-haven assets during a period of market volatility.
Thermo Fisher Scientific reported a strong finish to 2025, with Q4 results exceeding expectations. While navigating currency volatility and tariffs, the life sciences giant highlighted growth in core biopharma sectors, strategic acquisitions like Clario, and a solid 2026 outlook.
Investment bank Macquarie has lowered its price target for Chinese EV maker XPeng, pointing to reduced government subsidies and a complex path to profitability as the company expands its model lineup.
Despite a mixed analyst outlook, Morgan Stanley projects robust growth for Full Truck Alliance's core commission business, even as overall revenue faces headwinds. The digital freight platform's long-term strategy is gaining favor.
Investment bank Macquarie has raised its rating on NIO Inc. (NYSE:NIO) from Neutral to Outperform, citing better-than-expected fourth-quarter delivery figures and the growing success of its battery subscription model. The firm also increased its price target to $6.10.
Biotech firm Argenx SE sees its flagship drug Vyvgart outperform sales expectations in myasthenia gravis and CIDP treatments, with analysts pointing to sustained growth and regulatory momentum as key drivers.
Truist Securities has raised its price target for Amer Sports (NYSE: AS), citing the company's clear long-term roadmap and 'durable growth levers' across its portfolio of iconic sports brands. The firm sees a realistic path to earnings per share exceeding $2.50 by fiscal 2030.
As the FTSE indices reel from weak Chinese trade data, a screen of undervalued UK equities reveals potential opportunities. We examine three companies trading significantly below their estimated cash flow value.
As global economic headwinds persist, UK investors are turning to dividend-paying stocks for portfolio resilience. We analyze three FTSE-listed companies with strong income credentials and growth potential for the coming year.
Altria Group reported adjusted earnings growth and robust shareholder returns for 2025, even as it grapples with a rapidly transforming nicotine market dominated by illicit flavored vapes and intense competition in oral tobacco.
Australia reaffirms its commitment to building resilient critical mineral supply chains and a strategic reserve, undeterred by the U.S. stepping back from plans to guarantee minimum prices for such projects.
ResMed Inc. reports an 11% revenue surge for its second fiscal quarter, driven by robust mask sales and strategic acquisitions, while navigating competitive pressures and capitalizing on emerging healthcare trends.
KLA Corporation reports robust fiscal 2025 results driven by AI demand, but warns of supply constraints and geopolitical factors tempering near-term growth, with a significant acceleration projected for late 2026 and 2027.
